AbbVie Stock: To Buy Or Not To Buy (NYSE:ABBV) | Seeking Alpha
AbbVie (NYSE:ABBV) has been a quality power healthcare stock in Rose's Income Garden "RIG" portfolio since 2015. I added to it, on and off through the years, as the price was volatile and many become concerned it had taken on too much debt to acquire Pharmacyclics, a leading hematological oncology…
#fg #valueline #roseincomegarden #abbvie #skyrizi #analyzersoftwaretool #allergan #humira #botox #rinvoq